<table border="1"><tr><th>Trade names</th><td>Zyprexa, others</td></tr><tr><th>AHFS/Drugs.com</th><td>Monograph</td></tr><tr><th>MedlinePlus</th><td>a601213</td></tr><tr><th>License data</th><td>EU |  EMA | by INN | US |  DailyMed | Olanzapine | US | FDA: Olanzapine</td></tr><tr><th>Pregnancy | category</th><td>AU |  C</td></tr><tr><th>Routes of | administration</th><td>By mouth, intramuscular injection</td></tr><tr><th>Drug class</th><td>Atypical antipsychotic</td></tr><tr><th>ATC code</th><td>N05AH03 ( | WHO | )</td></tr><tr><th>Legal status</th><td>AU |  S4 (Prescription only) | CA | : ℞-only | NZ | : Prescription medicine | UK |  POM (Prescription only) | US |  ℞-only | EU |  Rx-only</td></tr><tr><th>Bioavailability</th><td>60-65%</td></tr><tr><th>Protein binding</th><td>93%</td></tr><tr><th>Metabolism</th><td>Liver (direct glucuronidation and CYP1A2 mediated oxidation)</td></tr><tr><th>Elimination | half-life</th><td>33 hours, 51.8 hours (elderly)</td></tr><tr><th>Excretion</th><td>Urine (57%; 7% as unchanged drug), faeces (30%)</td></tr><tr><th>Identifiers</th><td>IUPAC name | 2-Methyl-4-(4-methyl-1-piperazinyl)-10 | H | -thieno[2,3- | b | ][1,5]benzodiazepine</td></tr><tr><th>CAS Number</th><td>132539-06-1</td></tr><tr><th>PubChem | CID</th><td>4585</td></tr><tr><th>IUPHAR/BPS</th><td>47</td></tr><tr><th>DrugBank</th><td>DB00334</td></tr><tr><th>ChemSpider</th><td>10442212</td></tr><tr><th>UNII</th><td>N7U69T4SZR</td></tr><tr><th>KEGG</th><td>D00454</td></tr><tr><th>ChEBI</th><td>CHEBI:7735</td></tr><tr><th>ChEMBL</th><td>ChEMBL715</td></tr><tr><th>CompTox Dashboard | ( | EPA | )</th><td>DTXSID9023388</td></tr><tr><th>ECHA InfoCard</th><td>100.125.320</td></tr><tr><th>Formula</th><td>C | 17 | H | 20 | N | 4 | S</td></tr><tr><th>Molar mass</th><td>312.44 |  g·mol | −1</td></tr><tr><th>3D model (JSmol)</th><td>Interactive image</td></tr><tr><th>Melting point</th><td>195 °C (383 °F)</td></tr><tr><th>Solubility in water</th><td>Practically insoluble in water mg/mL (20 °C)</td></tr></table>